Insider Transactions in Q3 2022 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,122
-13.1%
|
$46,830
$15.25 P/Share
|
|
Sep 28
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,122
+11.58%
|
$6,244
$2.1 P/Share
|
|
Sep 28
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
3,085
-1.48%
|
$46,275
$15.23 P/Share
|
|
Sep 27
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,403
-10.39%
|
$36,045
$15.31 P/Share
|
|
Sep 27
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,403
+9.42%
|
$4,806
$2.1 P/Share
|
|
Sep 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
4,419
-1.04%
|
$66,285
$15.43 P/Share
|
|
Sep 26
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
1,544
-1.2%
|
$23,160
$15.79 P/Share
|
|
Sep 26
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,068
-6.53%
|
$46,020
$15.78 P/Share
|
|
Sep 26
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,068
+11.43%
|
$6,136
$2.1 P/Share
|
|
Sep 26
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
3,083
-0.72%
|
$46,245
$15.76 P/Share
|
|
Sep 23
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
939
-4.34%
|
$14,085
$15.09 P/Share
|
|
Sep 23
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
939
+4.16%
|
$1,878
$2.1 P/Share
|
|
Sep 23
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
1,018
-1.56%
|
$15,270
$15.07 P/Share
|
|
Sep 23
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,023
-0.47%
|
$15,345
$15.07 P/Share
|
|
Sep 21
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,341
-13.89%
|
$50,115
$15.08 P/Share
|
|
Sep 21
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,341
+12.19%
|
$6,682
$2.1 P/Share
|
|
Sep 21
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
3,275
-4.77%
|
$49,125
$15.13 P/Share
|
|
Sep 21
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
3,402
-1.55%
|
$51,030
$15.12 P/Share
|
|
Sep 15
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
106
-0.51%
|
$1,590
$15.01 P/Share
|
|
Sep 15
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
106
+0.51%
|
$212
$2.1 P/Share
|
|
Sep 15
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
100
-0.15%
|
$1,500
$15.01 P/Share
|
|
Sep 15
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
200
-0.09%
|
$3,000
$15.04 P/Share
|
|
Sep 09
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
800
-3.72%
|
$12,000
$15.07 P/Share
|
|
Sep 09
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+3.58%
|
$1,600
$2.1 P/Share
|
|
Sep 09
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
865
-1.24%
|
$12,975
$15.06 P/Share
|
|
Sep 09
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
688
-0.31%
|
$10,320
$15.07 P/Share
|
|
Sep 08
2022
|
Nerissa Kreher Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,221
-5.57%
|
$18,315
$15.13 P/Share
|
|
Sep 08
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,221
+5.27%
|
$2,442
$2.1 P/Share
|
|
Sep 08
2022
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
912
-1.29%
|
$13,680
$15.15 P/Share
|
|
Sep 08
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,100
-0.5%
|
$16,500
$15.16 P/Share
|
|
Sep 01
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,503
+25.02%
|
-
|
|
Sep 01
2022
|
Natarajan Sethuraman President, Research & Develop. |
BUY
Grant, award, or other acquisition
|
Direct |
5,794
+3.45%
|
-
|
|
Sep 01
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,172
+19.98%
|
-
|
|
Sep 01
2022
|
Nathan J Dowden President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
5,632
+7.4%
|
-
|
|
Sep 01
2022
|
Dipal Doshi CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,125
+6.38%
|
-
|
|
Aug 31
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
171
-0.08%
|
$2,052
$12.0 P/Share
|
|
Aug 30
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
190
-0.09%
|
$2,280
$12.0 P/Share
|
|
Aug 29
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,639
-0.26%
|
$21,307
$13.36 P/Share
|
|
Aug 25
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,551
-12.37%
|
$21,714
$14.18 P/Share
|
|
Aug 24
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,118
-10.17%
|
$40,534
$13.88 P/Share
|
|
Aug 24
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,117
+6.66%
|
$2,234
$2.1 P/Share
|
|
Aug 23
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,909
-16.67%
|
$37,817
$13.09 P/Share
|
|
Aug 23
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,403
+7.44%
|
$2,806
$2.1 P/Share
|
|
Aug 22
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
217
-1.33%
|
$2,821
$13.0 P/Share
|
|
Aug 22
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
117
+0.71%
|
$234
$2.1 P/Share
|
|
Aug 19
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,529
-34.57%
|
$110,877
$13.08 P/Share
|
|
Aug 19
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,452
+15.29%
|
$8,904
$2.1 P/Share
|
|
Aug 18
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-0.98%
|
$2,600
$13.0 P/Share
|
|
Aug 18
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.49%
|
$200
$2.1 P/Share
|
|
Aug 17
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-0.97%
|
$2,600
$13.07 P/Share
|